Daniel Garin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Daniel Garin

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Antiviral Therapy|February 5, 2008

Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft culturesSophie Duraffour, Robert Snoeck, Rita de Vos, et al.

Antiviral Therapy|February 7, 2009

Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differentlySophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.

European Journal of Immunology|August 30, 2012

NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patientsAlexandre Harari, Virginie Rozot, Matthias Cavassini, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Antiviral Therapy|February 5, 2008

Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft culturesSophie Duraffour, Robert Snoeck, Rita de Vos, et al.

Antiviral Therapy|February 7, 2009

Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differentlySophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.

European Journal of Immunology|August 30, 2012

NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patientsAlexandre Harari, Virginie Rozot, Matthias Cavassini, et al.

Pageof 4